Harrow Health (HROW) Tops Q2 EPS by 12c

Harrow Health (NASDAQ: HROW) reported Q2 EPS of ($0.06), $0.12 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $48.94 million versus the consensus estimate of $42.51 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Alphabet to replace Verizon in the Dow Jones Industrial Average
• Worthington Industries (WOR) Misses Q4 EPS by 9c